BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32126886)

  • 1. Statin treatment of patients with calcific aortic valve disease modulates extracellular adenosine metabolism on the cell surface of the aortic valve.
    Kutryb-Zajac B; Jablonska P; Hebanowska A; Lango R; Rogowski J; Slominska EM; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1389-1399. PubMed ID: 32126886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleotide ecto-enzyme metabolic pattern and spatial distribution in calcific aortic valve disease; its relation to pathological changes and clinical presentation.
    Kutryb-Zajac B; Jablonska P; Serocki M; Bulinska A; Mierzejewska P; Friebe D; Alter C; Jasztal A; Lango R; Rogowski J; Bartoszewski R; Slominska EM; Chlopicki S; Schrader J; Yacoub MH; Smolenski RT
    Clin Res Cardiol; 2020 Feb; 109(2):137-160. PubMed ID: 31144065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor.
    Mahmut A; Boulanger MC; Bouchareb R; Hadji F; Mathieu P
    Cardiovasc Res; 2015 Apr; 106(1):109-20. PubMed ID: 25644539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization.
    Kaniewska-Bednarczuk E; Kutryb-Zajac B; Sarathchandra P; Pelikant-Malecka I; Sielicka A; Piotrowska I; Slominska EM; Chester AH; Yacoub MH; Smolenski RT
    Cardiovasc Pathol; 2018; 36():53-63. PubMed ID: 30056298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2 Is Downregulated in Human Stenotic Aortic Valves and Its Inhibition Promotes Dystrophic Calcification.
    Vieceli Dalla Sega F; Fortini F; Cimaglia P; Marracino L; Tonet E; Antonucci A; Moscarelli M; Campo G; Rizzo P; Ferrari R
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin alleviates the calcification of aortic valve interstitial cells through activating the PI3K/AKT pathway in an AMPK dependent way.
    En Q; Zeping H; Yuetang W; Xu W; Wei W
    Mol Med; 2021 Dec; 27(1):156. PubMed ID: 34895136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SALTIRE-RAAVE: targeting calcific aortic valve disease LDL-density-radius theory.
    Rajamannan NM; Greve AM; Moura LM; Best P; Wachtell K
    Expert Rev Cardiovasc Ther; 2015 Apr; 13(4):355-67. PubMed ID: 25797901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease.
    Cho KI; Sakuma I; Sohn IS; Jo SH; Koh KK
    Atherosclerosis; 2018 Oct; 277():60-65. PubMed ID: 30173080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.
    Hjortnaes J; Goettsch C; Hutcheson JD; Camci-Unal G; Lax L; Scherer K; Body S; Schoen FJ; Kluin J; Khademhosseini A; Aikawa E
    J Mol Cell Cardiol; 2016 May; 94():13-20. PubMed ID: 26996755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role of extracellular nucleotides in valve calcification: a potential target for atorvastatin.
    Osman L; Chester AH; Amrani M; Yacoub MH; Smolenski RT
    Circulation; 2006 Jul; 114(1 Suppl):I566-72. PubMed ID: 16820639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lipid theory in the pathogenesis of calcific aortic stenosis.
    Parisi V; Leosco D; Ferro G; Bevilacqua A; Pagano G; de Lucia C; Perrone Filardi P; Caruso A; Rengo G; Ferrara N
    Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):519-25. PubMed ID: 25816732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting vasoactive peptides for managing calcific aortic valve disease.
    Peltonen T; Ohukainen P; Ruskoaho H; Rysä J
    Ann Med; 2017 Feb; 49(1):63-74. PubMed ID: 27585243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification.
    Gomez-Stallons MV; Wirrig-Schwendeman EE; Hassel KR; Conway SJ; Yutzey KE
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1398-405. PubMed ID: 27199449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
    Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research progress on pharmacotherapy of calcific aortic valve disease].
    DU M; Ma G; Shi Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):432-438. PubMed ID: 27868419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Aortic Valve Interstitial Cells Display Proangiogenic Properties During Calcific Aortic Valve Disease.
    Gendron N; Rosa M; Blandinieres A; Sottejeau Y; Rossi E; Van Belle E; Idelcadi S; Lecourt S; Vincentelli A; Cras A; Jashari R; Chocron R; Baudouin Y; Pamart T; Bièche I; Nevo N; Cholley B; Rancic J; Staels B; Gaussem P; Dupont A; Carpentier A; Susen S; Smadja DM
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):415-429. PubMed ID: 33147990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid substance within stenotic aortic valves promotes mineralization.
    Audet A; Côté N; Couture C; Bossé Y; Després JP; Pibarot P; Mathieu P
    Histopathology; 2012 Oct; 61(4):610-9. PubMed ID: 22642224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.
    Novaro GM; Tiong IY; Pearce GL; Lauer MS; Sprecher DL; Griffin BP
    Circulation; 2001 Oct; 104(18):2205-9. PubMed ID: 11684632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells.
    Choi B; Lee S; Kim SM; Lee EJ; Lee SR; Kim DH; Jang JY; Kang SW; Lee KU; Chang EJ; Song JK
    Circulation; 2017 May; 135(20):1935-1950. PubMed ID: 28179397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydrotanshinone I inhibits aortic valve interstitial cell calcification via the SMAD1/5/8/NF-κB/ERK pathway.
    Wang Y; Weng Y; Li X; Huang Q; Xiang Y; Li X; Shi Q
    Biomed Pharmacother; 2021 Jul; 139():111674. PubMed ID: 34243610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.